The Centers for Disease Control and Prevention is changing its recommendations for COVID-19 vaccines to make clear that shots made by Moderna and Pfizer are preferred over Johnson & Johnson’s vaccine.
The CDC’s advisory committee endorsed the updated recommendation after hearing new data indicating a rare blood clotting syndrome is more common among people who recently got a J&J vaccine than previously believed.
Out of the 54 cases reported in the U.S., nine people have died.